Patent Assignment
Reel/Frame 054960/0591
Assignment of Assignor's Interest
Recorded: 2021-01-11
Pages: 33
Assignor
CATALYST BIOSCIENCES, INC.
Executed: 2016-10-14
Assignee
OYSTER POINT PHARMA, INC.
202 CARNEGIE CENTER, SUITE 109, PRINCETON, NEW JERSEY, 08540
Covered Property
(1)
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 11, 2021
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINDER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 054960/0420 →
Change of Name
Jan 11, 2021
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 055226/0671 →
Patent Security Agreement
Aug 5, 2021
From: OYSTER POINT PHARMA, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057104/0189 →
Release of Security Interest
Feb 3, 2023
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: OYSTER POINT PHARMA INC.
Reel/Frame 062582/0873 →